Influence of food and lifestyle on the risk of developing inflammatory bowel disease

Internal Medicine Journal

Volumn 46, Issue 6, 2016, Pages 669-676

  Niewiadomski, O ^a   Studd, C ^b   Wilson, J ^c   Williams, J ^a   Hair, C ^d   Knight, R ^d   Prewett, E ^d   Dabkowski, P ^d   Alexander, S ^d   Allen, B ^d   Dowling, D ^d   Connell, W ^a   Desmond, P ^a   Bell, S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

^c North West Regional Hospital   (Australia)

^d BARWON HEALTH   (Australia)

Author keywords

Aetiology; Crohn disease; Environmental factors; Epidemiology; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CAFFEINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; BREAST FEEDING; CHICKENPOX; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DIET; DISEASE REGISTRY; ENVIRONMENTAL EXPOSURE; EXPOSURE; FAST FOOD; FEMALE; FOOD INTAKE; FRUIT; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PET ANIMAL; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SMOKING; SWIMMING; TONSILLECTOMY; ULCERATIVE COLITIS; ADVERSE EFFECTS; CASE CONTROL STUDY; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; ODDS RATIO; REGISTER; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CASE-CONTROL STUDIES; CHICKENPOX; CHILD; DIET; FAST FOODS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RISK FACTORS; SMOKING; SURVEYS AND QUESTIONNAIRES; TONSILLECTOMY; YOUNG ADULT;

EID: 84971379293     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.13094     Document Type: Article

References (59)

1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.
2. Xavier RJ, Podolsky DK . Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-34.
3. Baumgart DC, Carding SR . Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-40.
4. Loftus CG, Loftus EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13: 254-61.
5. Niewiadomski O, Studd C, Hair C, Wilson J, Ding NS, Heerasing N et al. Prospective population-based cohort of inflammatory bowel disease in the biologics era: disease course and predictors of severity. J Gastroenterol Hepatol 2015; 30: 1346-53.
6. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn Colitis database. Am J Gastroenterol 2006; 101: 1274-82.
7. Ng S, Tang W, Ching J, Wong M . Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and Colitis Epidemiology Study. Gastroenterology 2013; 145: 158-65.
8. Lakatos L, Kiss LS, David G, Pandur T, Erdelyi Z, Mester G et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011; 17: 2558-65.
9. Burisch J, Pedersen N, Cukovi Cavka S, Brinar M, Kaimakliotis I, Duricova D et al. East-west gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014; 63: 588-97.
10. Vind I, Riis L, Jespersgaard C, Jess T, Knudsen E, Pedersen N et al. Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005. J Crohns Colitis 2008; 2: 162-9.
11. Halfvarson J, Jess T, Magnuson A, Montgomery SM, Orholm M, Tysk C et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006; 12: 925-33.
12. Hansen TS, Jess T, Vind I, Elkjaer M, Nielsen MF, Gamborg M et al. Environmental factors in inflammatory bowel disease: A case-control study based on a Danish inception cohort. J. Crohns Colitis 2011; 5: 577-84.
13. Ng SC, Tang W, Leong R, Chen M, Ko Y, Studd C et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut 2014; 64: 1063-71.
14. Russel MG, Dorant E, Brummer RJ, van de Kruijs MA, Muris JW, Bergers JM et al. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology 1997; 113: 377-82.
15. Loftus E . Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1506-17.
16. Wilson J, Hair C, Knight R, Catto-Smith A, Bell S, Kamm M et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian Incidence Study. Inflamm Bowel Dis 2010; 16: 1550-6.
17. Studd C, Cameron G, Beswick L, Knight R, Hair C, McNeil J et al. Never underestimate inflammatory bowel disease: high prevalence rates and confirmation of high incidence in Australia. J Gastroentroen Hepatol 2015; 31: 81-6.
18. Australian Bureau of Statistic s population estimates. [cited 2001 Nov 14]. Available from URL: www.abs.gov.au
19. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19: 5-36.
20. Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D et al. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe -An ECCO-EpiCom study. J Crohns Colitis 2014; 8: 607-16.
21. Kaplan GG . Global variations in environmental risk factors for IBD. Nat Rev Gastroenterol Hepatol 2014; 11: 708-9.
22. Gearry R, Richardson A, Frampton C, Collett J, Burt MBC et al. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 2006; 12: 1-8.
23. Chouraki V, Savoye G, Dauchet L, Vernier-Massouille G, Dupas JL, Merle V et al. The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10-to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 2011; 33: 1133-42.
24. Ko Y, Butcher R, Leong RW . Epidemiological studies of migration and environmental risk factors in the inflammatory bowel diseases. World J Gastroenterol 2014; 20: 1238-47.
25. Gearry RB . IBD and environment: are there differences between east and west. Dig Dis 2016; 34: 84-9.
26. Bernstein CN, Shanahan F . Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008; 57: 1185-91.
27. Russel MG, Engels LG, Muris JW, Limonard CB, Volovics A, Brummer RJ et al. Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998; 10: 243-9.
28. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007; 102: 2016-25.
29. Jakobsen C, Paerregaard A, Munkholm P, Wewer V . Environmental factors and risk of developing paediatric inflammatory bowel disease - A population based study 2007-2009. J Crohns Colitis 2013; 7: 79-88.
30. Galvez J, Rodriguez-Cabezas E, Zarzuelo A . Review: Effects of dietary fiber on inflammatory bowel disease. Mol Nut Food Res 2005; 49: 601-8.
31. Rose DJ, DeMeo MT, Keshavarzian A, Hamaker BR . Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. Nutr Rev 2007; 65: 51-62.
32. Hou JK, Lee D, Lewis J . Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol 2014; 12: 1592-600.
33. Geerling BJ, Dagnelie PC, Badart-Smook RD, Russel MG, Stockbrugger RW, RJM B . Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000; 95: 1008-12.
34. Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005; 11: 154-63.
35. Hart AR, Luben R, Olsen A, Tjonneland A, Linseisen J, Nagel G et al. Diet in the aetiology of ulcerative colitis: a European Prospective Cohort Study. Digestion 2008; 77: 57-64.
36. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 2014; 63: 776-84.
37. John S, Luben R, Shrestha SS, Welch A, Khaw K-T, Hart AR . Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol 2010; 22: 602-6.
38. Shoda R, Matsueda K, Yamato S, Umeda N . Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63: 741-5.
39. Hou JK, Abraham B, El-Serag H . Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011; 106: 563-73.
40. Jantchou P, Morois S, Clavel-Chapelon FCO, Boutron-Ruault M-C, Carbonnel F . Animal protein intake and risk of inflammatory bowel disease: the E3N Prospective Study. Am J Gastroenterol 2010; 105: 2195-201.
41. Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519: 92-6.
42. Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010; 51: 201-9.
43. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S . Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998; 30: 909-22.
44. di Mola FF, Di Sebastiano P, Gardini A, Innocenti P, Zimmermann A, Buchler MW et al. Differential expression of connective tissue growth factor in inflammatory bowel disease. Digestion 2004; 69: 245-53.
45. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML . Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010; 25: 325-33.
46. Koutroubakis IE, Vlachonikolis IG, Kapsoritakis A, Spanoudakis S, Roussomoustakaki M, Mouzas IA et al. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease. Dis Colon Rectum 1999; 42: 225-30.
47. Maté-Jimenez J, Correa-Estañ JA, Perez-Miranda M, Gomez-Cedenilla A, Pajares JM, Moreno-Otero R . Tonsillectomy and inflammatory bowel disease location. Eur J Gastroenterol Hepatol 1996; 8: 1185-8.
48. Blumer C, Roche P, Spencer J . Surveillance of viral pathogens in Australia: varicella-zoster virus. Commun Dis Intell Q Rep 2002; 26: 576.
49. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D . Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766-7.
50. Bach J-F . The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-20.
51. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 275-84.
52. Calkins BM . A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841-54.
53. Parkes GC, Whelan K, Lindsay JO . Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 2014; 8: 717-25.
54. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF . A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006; 101: 993-1002.
55. Birrenbach T, Böcker U . Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004; 10: 848-59.
56. Sutherland LR, Ramcharan S, Bryant H, Fick G . Effect of cigarette smoking on recurrence of Crohn's Disease. Gastroenterology 1990; 98: 1123-8.
57. De Vroey B, De Cassan C, Gower Rousseau C, Colombel J-F . Editorial: antibiotics earlier, IBD later? Am J Gastroenterol 2010; 105: 2693-6.
58. Shaw SY, Blanchard JF, Bernstein CN . Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 2010; 105: 2687-92.
59. van der Valk ME, Mangen MJJ, Leenders M, Dijkstra G, van Bodegraven AA, Fidder HH et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF therapy: results from the COIN study. Gut 2013; 63: 72-9.